Overview

Sildenafil for Chronic Obstructive Pulmonary Disease

Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if sildenafil improves the exercise capacity and lung function of patients with chronic obstructive pulmonary disease.
Phase:
Phase 2
Details
Lead Sponsor:
Kawut, Steven, MD
Collaborator:
Pfizer
Treatments:
Citric Acid
Sildenafil Citrate